Abstract
This review describes microbial transformation studies of natural drugs, its importance in correlating them with the corresponding metabolism (biotransformation) in animal system and in the structural modification of complex drug molecules, which are difficult to obtain synthetically. Emphasis is laid on the potential microorganisms, which mimic the pathways of mammalian metabolism and which involve in stereoselective, regiospecific and selective conversions of natural drugs to their derivatives by microorganisms, which are more useful and difficult to synthesize. This paper describes the present state-of-art, will elucidate the additional possibilities with microbial biotransformation of natural drugs, i.e., comparison of microbial transformation with mammalian metabolism and possibility of producing novel molecules, which are difficult to produce by other means.
Keywords: biotransformation, microorganisms, microbial metabolites, mammalian metabolites, stereoselective conversion, regiospecific conversion
Current Pharmaceutical Biotechnology
Title: Application of Microbial Biotransformation for the New Drug Discovery Using Natural Drugs as Substrates
Volume: 4 Issue: 3
Author(s): R. K. Venisetty and V. Ciddi
Affiliation:
Keywords: biotransformation, microorganisms, microbial metabolites, mammalian metabolites, stereoselective conversion, regiospecific conversion
Abstract: This review describes microbial transformation studies of natural drugs, its importance in correlating them with the corresponding metabolism (biotransformation) in animal system and in the structural modification of complex drug molecules, which are difficult to obtain synthetically. Emphasis is laid on the potential microorganisms, which mimic the pathways of mammalian metabolism and which involve in stereoselective, regiospecific and selective conversions of natural drugs to their derivatives by microorganisms, which are more useful and difficult to synthesize. This paper describes the present state-of-art, will elucidate the additional possibilities with microbial biotransformation of natural drugs, i.e., comparison of microbial transformation with mammalian metabolism and possibility of producing novel molecules, which are difficult to produce by other means.
Export Options
About this article
Cite this article as:
Venisetty K. R. and Ciddi V., Application of Microbial Biotransformation for the New Drug Discovery Using Natural Drugs as Substrates, Current Pharmaceutical Biotechnology 2003; 4 (3) . https://dx.doi.org/10.2174/1389201033489847
DOI https://dx.doi.org/10.2174/1389201033489847 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Non-ACE Pathway-induced Angiotensin II Production
Current Pharmaceutical Design Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Antagonists in Experimental Myocarditis
Current Pharmaceutical Design Dysregulation of LncRNAs in Placenta and Pathogenesis of Preeclampsia
Current Drug Targets CD36 as a Multiple-Ligand Signaling Receptor in Atherothrombosis
Cardiovascular & Hematological Agents in Medicinal Chemistry Sleep-Disordered Breathing and Cardiovascular Disease: Exploring Pathophysiology and Existing Data
Current Respiratory Medicine Reviews An Unusual Case of Reversible Empty Sella
Endocrine, Metabolic & Immune Disorders - Drug Targets Phenolic Composition, Antioxidant and Cytotoxic Prospective of three Linum species: A Potential Source of Novel Anticancer Pharmacophores
Current Organic Chemistry Polypharmacy in Cardiovascular Medicine: Problems and Promises!
Cardiovascular & Hematological Agents in Medicinal Chemistry The New Adipose Tissue and Adipocytokines
Current Diabetes Reviews Cellular Mechanisms for Diastolic Dysfunction in the Human Heart
Current Pharmaceutical Biotechnology Patients’ Illness Perceptions of Type 2 Diabetes: A Scoping Review
Current Diabetes Reviews Polycystic Ovary Syndrome and Infertility: From Molecular Perspective
Current Women`s Health Reviews Incretins and Preservation of Endothelial Function
Cardiovascular & Hematological Agents in Medicinal Chemistry Chronic Kidney Disease - Different Role for HDL?
Current Medicinal Chemistry 2-Indolinone Derivatives as Potent Urease Inhibitors
Letters in Drug Design & Discovery Efalizumab: A Biological Agent for the Treatment of Psoriasis
Reviews on Recent Clinical Trials Lycopene Protects Liver Against Ulcerative Colitis
Current Drug Therapy Liraglutide Therapy in a Prediabetic State: Rethinking the Evidence
Current Diabetes Reviews BELFAST Centenarians: A Case of Optimal Cardiovascular Risk?
Current Pharmaceutical Design Therapeutic Potential of Phosphodiesterase Inhibitors for Endothelial Dysfunction- Related Diseases
Current Pharmaceutical Design